Vanderbilt University Medical Center Nashville, TN, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Disclosure(s):
Tracy Frech, MD, MS: No financial relationships with ineligible companies to disclose
In this session, the prevention of digital ischemia through Raynaud's phenomenon assessment will be discussed. The key diagnostic components of the physical exam, laboratory testing, and imaging assessment will be reviewed. The rationale for state-of-the art treatment considerations for vascular-based therapeutics will be defined.
Learning Objectives:
Discuss a preventative approach for digital ischemia related to Raynaud’s Phenomenon.
Describe key diagnostic rheumatologic considerations in acute digital ischemia.
Define treatment options for rheumatic digital ischemia.
